EPS are drug-induced movement disorders in which the pyramidal tract that controls the movement of the nervous system is blocked by drugs that antagonize dopamine D2 receptors and affect the nigrostriatal dopamine pathway, resulting in extrapyramidal side effects. Here, DRD2 is linked to movement disorder.